Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of pharmaceutical composition for treating nephrolithiasis

A composition and technology for nephrolithiasis, applied in the field of medicine, to achieve the effects of inhibiting inflammatory response, reducing recurrence rate, and clinical drug safety

Active Publication Date: 2022-04-05
达州市中西医结合医院
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, many existing traditional Chinese medicine formulas often only focus on the effects of crushing, dissolving and expulsing stones, and there are no reports on improving the common and most painful clinical manifestations of various nephrolithiasis such as pain and renal pelvis and hydroureter Therefore, it is of great significance to provide a drug that can effectively treat nephrolithiasis, renal pelvis and hydroureter, and relieve pain

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of pharmaceutical composition for treating nephrolithiasis
  • A kind of pharmaceutical composition for treating nephrolithiasis
  • A kind of pharmaceutical composition for treating nephrolithiasis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Embodiment 1, the preparation of the pharmaceutical composition for the treatment of nephrolithiasis of the present invention

[0021] Take raw materials astragalus 30g, Eucommia 20g, Qumai 30g, Guizhi 15g, Desmodium 40g, Gallinarum 30g, Haijinsha 20g, talc 40g, Shiwei 20g, Salvia 20g, Alisma 15g, Corydalis 20g, Plantago 20g .

Embodiment 2

[0022] Embodiment 2, the preparation of the pharmaceutical composition for the treatment of nephrolithiasis of the present invention

[0023] Take raw materials astragalus 20g, Eucommia 10g, Qumai 20g, Guizhi 5g, Desmodium 30g, Gallinarum 20g, Haijinsha 10g, talc 30g, Shiwei 10g, Salvia 10g, Alisma 5g, Corydalis 10g, Plantago 10g .

Embodiment 3

[0024] Embodiment 3, the preparation of the pharmaceutical composition for the treatment of nephrolithiasis of the present invention

[0025] Take raw materials astragalus 40g, Eucommia 30g, Qumai 40g, Guizhi 25g, Desmodium 50g, Gallinarum 40g, Haijinsha 30g, talc 50g, Shiwei 30g, Salvia 30g, Alisma 25g, Corydalis 30g, Plantago 30g .

[0026] The beneficial effects of the pharmaceutical composition for treating nephrolithiasis prepared by the present invention are demonstrated through experimental examples below.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention provides a pharmaceutical composition for treating nephrolithiasis, which can effectively treat nephrolithiasis, shorten the treatment time of nephrolithiasis, inhibit inflammation, reduce the recurrence rate of calculi, and can obviously improve hydrops in renal pelvis and ureter, Alleviating the pain of nephrolithiasis and lumbago, the clinical curative effect is sure, the clinical medication is safe, and has excellent application prospect.

Description

technical field [0001] The invention belongs to the field of medicine, in particular to a pharmaceutical composition for treating nephrolithiasis. Background technique [0002] Nephrolithiasis, also known as Urinary calculi, refers to crystal substances formed in the renal collecting system or renal tubules, some of which remain in the renal collecting system, and some can be discharged into the ureter or bladder with urine. become ureteral or bladder stones. [0003] Nephrolithiasis is one of the common and frequently-occurring diseases of the urinary system. In different regions in the north and south of my country, the incidence rate of nephrolithiasis is between 3% and 14%. my country is also one of the three major stone disease countries and regions in the world. The disease has a high morbidity and recurrence rate, and can cause urinary tract obstruction, infection, renal failure, and systemic multi-system diseases, and severe cases may endanger the lives of patients. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/9066A61K31/18A61P13/12A61P13/04A61K33/12A61K35/57
CPCA61K36/481A61K36/46A61K36/36A61K36/54A61K36/185A61K36/53A61K35/57A61K36/12A61K33/12A61K36/11A61K36/537A61K36/884A61K36/66A61K36/68A61K36/9066A61K36/58A61K31/18A61P13/12A61P13/04A61K2300/00
Inventor 周波王刚汤晓莉陈方明魏谭军
Owner 达州市中西医结合医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com